Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What Growth Opportunities are Expected to Drive the Genetic Toxicology Testing Market’s CAGR Through 2034?

In the past few years, the size of the genetic toxicology testing market has expanded substantially. It’s projected to increase from $1.63 billion in 2024 to $1.8 billion in 2025, reflecting a compound annual growth rate (CAGR) of 10.4%. The expansion seen in the historic period is fundamentally due to factors such as prevalent public health emergencies, heightened globalization, a greater emphasis on personalized medicine, a soaring demand for rigorous testing solutions, and arising quantity of drugs.

The market size for genetic toxicology testing is anticipated to witness exponential growth in the forthcoming years. It is projected to expand to $2.64 billion in 2029 with a compound annual growth rate (CAGR) of 10.0%. This anticipated growth within the forecast period could be attributed to the escalating demand for testing novel foods, heightened awareness about potential hazards, increasing health and environmental concerns, growing regulatory scrutiny, greater reliance on in vitro testing methods, and the emergence of high-throughput screening platforms. Notable trends during the forecast period encompass developments in precision medicine and toxicogenomic, extensive risk communication, methodologies used for genetic toxicology testing, progressive risk assessment methodologies, the application of omics technologies, and progress in genomics and molecular biology.

What Market Dynamics Are Playing a Key Role in Accelerating the Growth of the Genetic Toxicology Testing Market?

Personalized medicine’s growing demand is forecasted to fuel the expansion of the genetic toxicology testing market. Personalized medicine is a healthcare approach that personalizes healthcare decisions, practices, interventions, and products based on an individual’s anticipated response or disease risk. Factors like genetic breakthroughs, an improved understanding of diseases, the presence of diagnostics based on biomarkers, value-based healthcare programs, and integration into clinical practice and research have all contributed to a positive surge in the personalized medicine market. Genetic toxicology testing adds value to personalized medicine by offering crucial details about genetic variability, genotoxic agent susceptibility, and treatment response. For example, the Personalized Medicine Coalition, a US-based non-profit organization, revealed in February 2024 that the FDA approved 16 new personalized medicines for patients with rare diseases in 2023, an increase from six in 2022. Therefore, the escalating demand for personalized medicine is triggering the growth of the genetic toxicology testing market.

Get Your Free Sample of the Global Genetic Toxicology Testing Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=15574&type=smp

What Are the Leading Industry Players Dominating the Genetic Toxicology Testing Market?

Major companies operating in the genetic toxicology testing market are:

• Amazon.com Inc.

• Apple Inc.

• Target Corporation

• American Express

• Best Buy Co. Inc.

What Are the Latest Trends Leading to Disruption in the Genetic Toxicology Testing Market?

Major players in the genetic toxicology testing market are seeking to enhance accuracy and efficiency in identifying potential genetic toxins by creating novel drug screening platforms, such as phenotypic drug screening. This method involves testing compounds based on their capacity to elicit a specific cellular or physiological response in an entire organism or a relevant cell system, and is typically employed in drug discovery. Case in point, Creative Biogene, a biotechnology firm from the US, introduced zebrafish disease models in August 2022 to aid drug discovery and toxicology research. These models are engineered to simulate human genetic diseases in zebrafish, in order to gain insights into disease development, drug discovery, and toxicology. The zebrafish models from Creative Biogene prove to be a significant resource for gauging drug toxicity, projecting the safety of novel compounds, and to assist in drug development.

Get Instant Access to the Global Genetic Toxicology Testing Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/genetic-toxicology-testing-global-market-report

What Major Market Segments Define the Scope and Growth of the Genetic Toxicology Testing Market?

The genetic toxicology testing market covered in this report is segmented –

1) By Type: In Vitro, In Vivo

2) By Product: Services, Reagents And Consumables, Assays

3) By Application: Healthcare Industry, Food Industry, Cosmetics Industry, Agriculture Industry, Other Applications

Subsegments:

1) By In Vitro: Ames Test, Micronucleus Assay, Comet Assay, Chromosomal Aberration Test, Cell Transformation Assay, Other In Vitro Methods

2) By In Vivo: Micronucleus Test (Rodent), Comet Assay (In Vivo), Bone Marrow Chromosomal Aberration Test, Dominant Lethal Test (Rodent), Other In Vivo Methods

Which Regions Are Significant to the Growth of the Genetic Toxicology Testing Market?

North America was the largest region in the genetic toxicology testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genetic toxicology testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Can We Define the Genetic Toxicology Testing Market and Its Key Components?

Genetic toxicology testing is a branch of toxicology that focuses on assessing the potential of chemical substances to cause damage to genetic material, such as DNA, RNA, or chromosomes. The purpose of genetic toxicology testing is to evaluate the genotoxicity of compounds and identify any adverse effects they may have on the genetic material of living organisms, including humans. It is also a critical tool for evaluating the safety of pharmaceuticals, chemicals, and environmental pollutants from genotoxic hazards.

Browse Through More Similar Reports By The Business Research Company:

ADME Toxicology Testing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/adme-toxicology-testing-global-market-report

Genetic Testing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report

Genetically Modified Crops Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/genetically-modified-crops-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: